Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Sankyo discovers gelatinase inhibitors

July 18, 1997

Preliminary results reported for lisofylline in acute myeloid leukemia phase II trial

July 17, 1997

Final dosimetry analysis of phase II/III trial of Oncolym

July 17, 1997

Cell Pathways reports chemoprotective activity of sulindac sulfone in animal model

July 17, 1997

Survival rates after radical prostatectomy estimated

July 16, 1997

Peptidomimetic protein farnesyltransferase inhibitors from Merck & Co.

July 16, 1997

Cholecalciferols for leukemia prepared at Roche

July 16, 1997

Roussel Uclaf describes antiandrogenic compounds

July 16, 1997

Parke-Davis protein tyrosine kinase inhibitor has multiple activities

July 16, 1997

Vitamin B12 depletion reported to induce apoptosis

July 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.